Role of Salvage Radiation Therapy for Patients With Relapsed or Refractory Hodgkin Lymphoma Who Failed Autologous Stem Cell Transplant

Cell Transplant ◽

Salvage Radiation Therapy ◽

9224 Role of salvage radiation therapy in Hodgkin Lymphoma with relapsed or progressive disease despite autologous stem cell transplant

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71915-9 ◽

2009 ◽

Vol 7 (2) ◽

pp. 567

Author(s):

J.S. Goda ◽

C. Massey ◽

J. Kuruvilla ◽

M. Gospodarowicz ◽

W. Wells ◽

...

Keyword(s):

Radiation Therapy ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Progressive Disease ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Salvage Radiation Therapy

Consolidative Radiation Therapy Following Autologous Stem Cell Transplant in Relapsed or Refractory Hodgkin Lymphoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.173 ◽

2020 ◽

Vol 108 (3) ◽

pp. e752

Author(s):

M. Frick ◽

S.M. Hiniker ◽

C. Yoo ◽

R.T. Hoppe

Keyword(s):

Radiation Therapy ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma

Indian Journal of Hematology and Blood Transfusion ◽

10.1007/s12288-021-01490-1 ◽

2021 ◽

Author(s):

Jaikumar Patel ◽

Akanksha Garg ◽

Kinnari Patel ◽

Kamlesh Shah ◽

Sanket Shah ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Can Peri-Transplant Radiation Therapy Improve Outcomes of Autologous Stem Cell Transplant in Hodgkin Lymphoma?

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.12.473 ◽

2020 ◽

Vol 26 (3) ◽

pp. S231-S232

Author(s):

Harsh Shah ◽

Hyejeong Jang ◽

Seongho Kim ◽

Jorgena Kosti ◽

Paramveer Singh ◽

...

Keyword(s):

Radiation Therapy ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant

Patients with Relapsed/Refractory Large Cell Lymphoma Who Were Also Refractory to Salvage Chemotherapy: Outcome with Salvage Radiation Therapy Followed by Autologous Stem Cell Transplant

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.311 ◽

2018 ◽

Vol 102 (3) ◽

pp. S125

Author(s):

J.C. Yang ◽

K. Chau ◽

M. Scordo ◽

C.S. Sauter ◽

J. Yahalom

Keyword(s):

Radiation Therapy ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Lymphoma ◽

Large Cell ◽

Salvage Chemotherapy ◽

Cell Transplant ◽

Salvage Radiation Therapy ◽

Large Cell Lymphoma

Faculty Opinions recommendation of Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718026606.793482211 ◽

2013 ◽

Author(s):

Nelson Chao

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Biomarker analysis of pivotal phase II study of oral panobinostat (PAN) in relapsed/refractory Hodgkin lymphoma (HL) patients following autologous stem cell transplant (ASCT).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8046 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8046-8046 ◽

Cited By ~ 2

Author(s):

S. J. Harrison ◽

A. K. Hsu ◽

P. J. Neeson ◽

A. Younes ◽

A. Sureda ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Phase Ii ◽

Stem Cell Transplant ◽

Phase Ii Study ◽

Cell Transplant ◽

Pivotal Phase ◽

Biomarker Analysis ◽

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Leukemia & Lymphoma ◽

10.3109/10428194.2013.820287 ◽

2013 ◽

Vol 55 (5) ◽

pp. 1053-1060 ◽

Cited By ~ 8

Author(s):

Simon J. Harrison ◽

Andy K. Hsu ◽

Paul Neeson ◽

Anas Younes ◽

Anna Sureda ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant ◽

The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplant

Expert Review of Hematology ◽

10.1586/ehm.12.41 ◽

2012 ◽

Vol 5 (5) ◽

pp. 483-486 ◽

Cited By ~ 6

Author(s):

Bastian von Tresckow ◽

Andreas Engert

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Cell Transplant

Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study

European Journal Of Haematology ◽

10.1111/ejh.12973 ◽

2017 ◽

Vol 99 (6) ◽

pp. 553-558 ◽

Cited By ~ 7

Author(s):

Paul J. Bröckelmann ◽

Erin A. Zagadailov ◽

Shelby L. Corman ◽

Viktor Chirikov ◽

Courtney Johnson ◽

...

Keyword(s):

United Kingdom ◽

Stem Cell ◽

Retrospective Study ◽

Hodgkin Lymphoma ◽

Stem Cell Transplant ◽

Brentuximab Vedotin ◽

Cell Transplant ◽